Flohé Sascha, Lendemans Sven, Selbach Christian, Waydhas Christian, Ackermann Marcus, Schade F Ulrich, Kreuzfelder Ernst
Department of Trauma Surgery, University Hospital of Essen, Germany.
Crit Care Med. 2003 Oct;31(10):2462-9. doi: 10.1097/01.CCM.0000089640.17523.57.
Severe injury compromises functions of the antigen-presenting immune cells, resulting in an increased vulnerability toward bacterial sepsis. Support of the immune capabilities contributes a desirable therapeutic option in high-risk patients. Factors possessing immunostimulating properties such as granulocyte-macrophage colony-stimulating factor (GM-CSF) may serve as potential tools to compensate immunosuppression caused by severe trauma. In the present study, therefore, GM-CSF was examined with regard to its capacity to overcome trauma-induced down-regulation of immune functions.
Prospective clinical experimental study.
University hospital intensive care unit and research facility.
Severely injured patients with >25 points on the Injury Severity Score.
Blood samples of severely injured patients were incubated in vitro with 10 ng/mL GM-CSF for 6 hrs.
Human leukocyte antigen (HLA)-DR expression on monocytes was analyzed by flow cytometry, lipopolysaccharide-induced tumor necrosis factor (TNF)alpha and interleukin-10 production of blood samples was measured by means of enzyme-linked immunoabsorbent assay.
Compared with blood specimens of healthy donors, ex vivo endotoxin-induced TNF alpha production and HLA-DR expression on monocytes were significantly reduced in blood of trauma patients. Ex vivo treatment of blood specimens with GM-CSF increased HLA-DR expression and TNF alpha production stimulated by lipopolysaccharides in both healthy volunteers and patients on day 1 after trauma. Blood samples of patients with an uneventful recovery showed nearly normal TNF alpha synthesis and HLA-DR expression after 2-3 wks, whereas TNF alpha production and HLA-DR expression of patients with sepsis and multiple organ failure remained at low levels. In the sepsis/multiple organ failure group, GM-CSF also enhanced HLA-DR expression and TNF alpha production, although the levels of the volunteers' blood were not reached.
The presented data show that trauma- and sepsis-induced depression of monocyte functions can be counteracted by GM-CSF in vitro, suggesting that this substance may serve as support of immune functions in severely injured patients.
严重损伤会损害抗原呈递免疫细胞的功能,导致对细菌性败血症的易感性增加。支持免疫功能为高危患者提供了一种理想的治疗选择。具有免疫刺激特性的因子,如粒细胞巨噬细胞集落刺激因子(GM-CSF),可能作为补偿严重创伤引起的免疫抑制的潜在工具。因此,在本研究中,对GM-CSF克服创伤诱导的免疫功能下调的能力进行了研究。
前瞻性临床实验研究。
大学医院重症监护病房和研究机构。
损伤严重度评分>25分的重伤患者。
重伤患者的血样在体外与10 ng/mL GM-CSF孵育6小时。
通过流式细胞术分析单核细胞上人类白细胞抗原(HLA)-DR的表达,通过酶联免疫吸附测定法测量血样中脂多糖诱导的肿瘤坏死因子(TNF)α和白细胞介素-10的产生。
与健康供者的血样相比,创伤患者血液中内毒素诱导的TNFα产生和单核细胞上的HLA-DR表达显著降低。在创伤后第1天,用GM-CSF对健康志愿者和患者的血样进行体外处理,可增加脂多糖刺激的HLA-DR表达和TNFα产生。恢复顺利的患者血样在2-3周后显示TNFα合成和HLA-DR表达接近正常,而败血症和多器官功能衰竭患者的TNFα产生和HLA-DR表达仍处于低水平。在败血症/多器官功能衰竭组中,GM-CSF也增强了HLA-DR表达和TNFα产生,尽管未达到志愿者血液的水平。
所呈现的数据表明,GM-CSF在体外可抵消创伤和败血症诱导的单核细胞功能抑制,提示该物质可作为重伤患者免疫功能的支持。